Back
Neurogene Stock Predictions
Sponsored
NGNE
Sponsored
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
14
NGNE
Neurogene
Last Price:
$23.88
Seasonality Move:
23.27%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.Neurogene Stock Forecast
-
Over the next 52 weeks, Neurogene has on average historically risen by 47.5% based on the past 10 years of stock performance.
-
Neurogene has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Neurogene Stock Undervalued?The current Neurogene [NGNE] share price is $22.62. The Score for NGNE is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Neurogene Stock Go Up Next Year?
-
Over the next 52 weeks, Neurogene has on average historically risen by 47.5% based on the past 10 years of stock performance.
Neurogene Stock Rating
Sell
14
Neurogene (NGNE)
is a Sell
Is Neurogene overpriced?
-
Neurogene has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Neurogene Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com
52-Week Data
52-Week High:
74.49
52-Week Low:
14.44
Prediction Charts
Market Cap:
336M
Price in USD:
22.62
Volume:
76.1K
Beta:
-1.35
Technical Analysis
SMA50:
36.34
SMA100:
37.74
SMA200:
37.73
52-Wk Change:
46.88%
Stock Predictions
-
Is Neurogene stock public?Yes, Neurogene is a publicly traded company.
-
What is the Neurogene stock quote today?The Neurogene stock price is 22.62 USD today.
-
How to buy Neurogene stock online?You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-5 | 22.04 | 21.99 | 22.59 | 21.44 |
Dec-6 | 22.38 | 23.72 | 24.17 | 21.49 |
Dec-9 | 23.94 | 23.31 | 25.53 | 23.00 |
Dec-10 | 23.26 | 23.70 | 25.11 | 22.99 |
Dec-11 | 24.17 | 23.20 | 24.20 | 22.59 |
Dec-12 | 22.92 | 22.34 | 24.06 | 21.68 |
Dec-13 | 22.44 | 23.51 | 24.37 | 21.85 |
Dec-16 | 23.36 | 25.13 | 25.18 | 22.97 |
Dec-17 | 24.74 | 23.72 | 25.35 | 22.92 |
Dec-18 | 23.97 | 21.79 | 24.02 | 21.75 |
Dec-19 | 22.02 | 22.08 | 23.20 | 21.34 |
Dec-20 | 21.78 | 22.64 | 23.89 | 21.51 |
Dec-23 | 22.65 | 22.50 | 22.92 | 21.99 |
Dec-24 | 22.27 | 22.62 | 22.85 | 22.03 |
Neurogene Earnings
Neurogene Earnings Report: Per Share Neurogene Earnings Q1 Q2 Q3 and Q4 last year and next year.
Neurogene Forecast Revenue Growth
Neurogene Stock Analysis: Historical quarterly revenues per share for Neurogene and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.
* Neurogene stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.